$GoodRx Holdings, Inc.(GDRX)$ #earnings

Third quarter financial results exceed previously announced guidance

SANTA MONICA, Calif.--(BUSINESS WIRE)--Nov. 8, 2022-- GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital platform, has released its financial results for the third quarter of 2022.

Third Quarter 2022 Highlights

Total revenue of $187.3 million, exceeding previously announced guidance

Net loss of $41.71 million; Net loss margin of 22.3%

Adjusted Net Income2 of $29.9 million; Adjusted Net Income Margin2 of 16.0%

Adjusted EBITDA2 of $52.0 million; Adjusted EBITDA Margin2 of 27.8%, exceeding previously announced guidance

Net cash provided by operating activities of $33.7 million

Over 865,000 prescribers active on GoodRx in the last 16 months3

Exited the quarter with over 7 million consumers of prescription-related offerings4

“We are pleased with the progress made in the third quarter despite near-term challenges,” said Doug Hirsch, co-CEO and co-founder of GoodRx. “We achieved better-than-expected results and addressed the grocer issue in August. While we continued to see some impact from the grocer issue as we expected, the third quarter was highlighted by double-digit growth in our subscription and pharma manufacturer solutions platforms. Our retail and PBM partnerships remain resilient, and we expanded and enhanced our overall ecosystem this quarter while engaging more deeply with providers and consumers as we work to improve access to affordable healthcare.”

“Looking ahead, we will continue to prioritize profitability and cash flow, while efficiently expanding our core platform capabilities to scale our business, strengthen our value proposition, and leverage our strong brand to reach more consumers. I am proud of the progress the GoodRx team made this quarter, and I look forward to improving upon it over the quarters to come as we further our mission while creating value for shareholders,” concluded Hirsch.